EBIO - 3.37 Pre-market already up to 3.98/4.05. Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company http://stockcharts.com/c-sc/sc?s=EBIO&p=D&b=5&g=0&i=t12774711421&r=1474461430161 http://stockcharts.com/c-sc/sc?s=EBIO&p=W&b=5&g=0&i=t13330346000&r=1474461464602